Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
by
Kasamatsu, Atsushi
, Nozaki, Ryunosuke
, Ando, Toshiaki
, Nobuchi, Takafumi
, Kawasaki, Kohei
, Uzawa, Katsuhiro
, Iyoda, Manabu
, Saito, Tomoaki
in
AKT protein
/ Apoptosis
/ Cancer therapies
/ Caspase-3
/ Cell growth
/ Cell viability
/ Chemoresistance
/ Chemotherapy
/ Cisplatin
/ Drug dosages
/ Experiments
/ Extracellular signal-regulated kinase
/ Ginkgolides
/ Intracellular
/ Intracellular signalling
/ Medical prognosis
/ Oral carcinoma
/ Oral squamous cell carcinoma
/ Patients
/ Phosphorylation
/ Platelet-activating factor
/ Proteins
/ Signal transduction
/ Therapeutic applications
/ Therapeutic targets
/ Tumors
/ Variance analysis
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
by
Kasamatsu, Atsushi
, Nozaki, Ryunosuke
, Ando, Toshiaki
, Nobuchi, Takafumi
, Kawasaki, Kohei
, Uzawa, Katsuhiro
, Iyoda, Manabu
, Saito, Tomoaki
in
AKT protein
/ Apoptosis
/ Cancer therapies
/ Caspase-3
/ Cell growth
/ Cell viability
/ Chemoresistance
/ Chemotherapy
/ Cisplatin
/ Drug dosages
/ Experiments
/ Extracellular signal-regulated kinase
/ Ginkgolides
/ Intracellular
/ Intracellular signalling
/ Medical prognosis
/ Oral carcinoma
/ Oral squamous cell carcinoma
/ Patients
/ Phosphorylation
/ Platelet-activating factor
/ Proteins
/ Signal transduction
/ Therapeutic applications
/ Therapeutic targets
/ Tumors
/ Variance analysis
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
by
Kasamatsu, Atsushi
, Nozaki, Ryunosuke
, Ando, Toshiaki
, Nobuchi, Takafumi
, Kawasaki, Kohei
, Uzawa, Katsuhiro
, Iyoda, Manabu
, Saito, Tomoaki
in
AKT protein
/ Apoptosis
/ Cancer therapies
/ Caspase-3
/ Cell growth
/ Cell viability
/ Chemoresistance
/ Chemotherapy
/ Cisplatin
/ Drug dosages
/ Experiments
/ Extracellular signal-regulated kinase
/ Ginkgolides
/ Intracellular
/ Intracellular signalling
/ Medical prognosis
/ Oral carcinoma
/ Oral squamous cell carcinoma
/ Patients
/ Phosphorylation
/ Platelet-activating factor
/ Proteins
/ Signal transduction
/ Therapeutic applications
/ Therapeutic targets
/ Tumors
/ Variance analysis
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
Journal Article
Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway
2021
Request Book From Autostore
and Choose the Collection Method
Overview
The platelet-activating factor receptor (PAFR) is a key molecule that participates in intracellular signaling pathways, including regulating the activation of kinases. It is involved in cancer progression, but the detailed mechanism of its chemosensitivity is unknown. The purpose of the current study was to elucidate the mechanism regulating cisplatin (CDDP) sensitivity through PAFR functions in oral squamous cell carcinoma (OSCC). We first analyzed the correlation between PAFR expression and CDDP sensitivity in seven OSCC-derived cell lines based upon cell viability assays. Among them, we isolated 2 CDDP-resistant cell lines (Ca9-22 and Ho-1-N-1). In addition to conducting PAFR-knockdown (si
) experiments, we found that ginkgolide B (GB), a specific inhibitor of PAFR, enhanced both CDDP chemosusceptibility and apoptosis. We next evaluated the downstream signaling pathway of PAFR in si
-treated cells and GB-treated cells after CDDP treatment. In both cases, we observed decreased phosphorylation of ERK and Akt and increased expression of cleaved caspase-3. These results suggest that PAFR is a therapeutic target for modulating CDDP sensitivity in OSCC cells. Thus, GB may be a novel drug that could enhance combination chemotherapy with CDDP for OSCC patients.
Publisher
MDPI AG
Subject
This website uses cookies to ensure you get the best experience on our website.